SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-024258
Filing Date
2020-02-24
Accepted
2020-02-24 16:12:34
Documents
45
Period of Report
2020-02-24
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm209740d1_8k.htm   iXBRL 8-K 25704
2 EXHIBIT 99.1 tm209740d1_ex99-1.htm EX-99.1 116370
3 EXHIBIT 99.2 tm209740d1_ex99-2.htm EX-99.2 38088
7 GRAPHIC tm209740d1_ex99-1img001.jpg GRAPHIC 3670
8 GRAPHIC tm209740d1_ex99-2img001.jpg GRAPHIC 276745
9 GRAPHIC tm209740d1_ex99-2img002.jpg GRAPHIC 279296
10 GRAPHIC tm209740d1_ex99-2img003.jpg GRAPHIC 95956
11 GRAPHIC tm209740d1_ex99-2img004.jpg GRAPHIC 206786
12 GRAPHIC tm209740d1_ex99-2img005.jpg GRAPHIC 283407
13 GRAPHIC tm209740d1_ex99-2img006.jpg GRAPHIC 299557
14 GRAPHIC tm209740d1_ex99-2img007.jpg GRAPHIC 232677
15 GRAPHIC tm209740d1_ex99-2img008.jpg GRAPHIC 323318
16 GRAPHIC tm209740d1_ex99-2img009.jpg GRAPHIC 231971
17 GRAPHIC tm209740d1_ex99-2img010.jpg GRAPHIC 286887
18 GRAPHIC tm209740d1_ex99-2img011.jpg GRAPHIC 219515
19 GRAPHIC tm209740d1_ex99-2img012.jpg GRAPHIC 322042
20 GRAPHIC tm209740d1_ex99-2img013.jpg GRAPHIC 223374
21 GRAPHIC tm209740d1_ex99-2img014.jpg GRAPHIC 140387
22 GRAPHIC tm209740d1_ex99-2img015.jpg GRAPHIC 110433
23 GRAPHIC tm209740d1_ex99-2img016.jpg GRAPHIC 229956
24 GRAPHIC tm209740d1_ex99-2img017.jpg GRAPHIC 152802
25 GRAPHIC tm209740d1_ex99-2img018.jpg GRAPHIC 290235
26 GRAPHIC tm209740d1_ex99-2img019.jpg GRAPHIC 252182
27 GRAPHIC tm209740d1_ex99-2img020.jpg GRAPHIC 255619
28 GRAPHIC tm209740d1_ex99-2img021.jpg GRAPHIC 178425
29 GRAPHIC tm209740d1_ex99-2img022.jpg GRAPHIC 242820
30 GRAPHIC tm209740d1_ex99-2img023.jpg GRAPHIC 318005
31 GRAPHIC tm209740d1_ex99-2img024.jpg GRAPHIC 215660
32 GRAPHIC tm209740d1_ex99-2img025.jpg GRAPHIC 294462
33 GRAPHIC tm209740d1_ex99-2img026.jpg GRAPHIC 232288
34 GRAPHIC tm209740d1_ex99-2img027.jpg GRAPHIC 141808
35 GRAPHIC tm209740d1_ex99-2img028.jpg GRAPHIC 96221
36 GRAPHIC tm209740d1_ex99-2img029.jpg GRAPHIC 103011
37 GRAPHIC tm209740d1_ex99-2img030.jpg GRAPHIC 223247
  Complete submission text file 0001104659-20-024258.txt   9674036

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA tbph-20200224.xsd EX-101.SCH 3192
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE tbph-20200224_lab.xml EX-101.LAB 34591
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tbph-20200224_pre.xml EX-101.PRE 22714
41 EXTRACTED XBRL INSTANCE DOCUMENT tm209740d1_8k_htm.xml XML 3625
Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Filer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36033 | Film No.: 20644420
SIC: 2834 Pharmaceutical Preparations